Literature DB >> 30324479

ASO Author Reflections: Fluorescent Anti-CEA IR800 for Tumor Labeling.

Thinzar M Lwin1,2,3, Michael Bouvet4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30324479      PMCID： PMC7243965          DOI： 10.1245/s10434-018-6905-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation.

Authors:  Lindsay S Moore; Eben L Rosenthal; Esther de Boer; Andrew C Prince; Neel Patel; Joshua M Richman; Anthony B Morlandt; William R Carroll; Kurt R Zinn; Jason M Warram
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

2.  Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.

Authors:  Thinzar M Lwin; Takashi Murakami; Kentaro Miyake; Paul J Yazaki; John E Shivley; Robert M Hoffman; Michael Bouvet
Journal:  Ann Surg Oncol       Date:  2018-01-25       Impact factor: 5.344

Review 3.  The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  Expert Rev Anticancer Ther       Date:  2018-05-28       Impact factor: 4.512

Review 4.  Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins.

Authors:  Martin C Boonstra; Susanna W L de Geus; Hendrica A J M Prevoo; Lukas J A C Hawinkels; Cornelis J H van de Velde; Peter J K Kuppen; Alexander L Vahrmeijer; Cornelis F M Sier
Journal:  Biomark Cancer       Date:  2016-09-27

5.  Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue.

Authors:  L S F Boogerd; F A Vuijk; C E S Hoogstins; H J M Handgraaf; M J M van der Valk; P J K Kuppen; C F M Sier; C J H van de Velde; J Burggraaf; A Fariña-Sarasqueta; Alexander L Vahrmeijer
Journal:  Biomark Cancer       Date:  2017-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.